Member Info for CityTTrader

Nice.

https://uk.advfn.com/stock-market/london/tiziana-life-sciences-TILS/share-news/Tiziana-Life-Sciences-PLC-Interview-to-Air-on-Bloo/82835263

Tiziana Life Sciences PLC

10 July 2020

Tiziana Life Sciences plc

("Tiziana" or the "Company")

Tiziana Life Sciences Interview to Air on Bloomberg International on the RedChip Money Report

NEW YORK and LONDON, July 10, 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a clinical stage biotechnology company developing targeted drugs for cancer, inflammatory diseases and COVID-19, today announced an interview with Kunwar Shailubhai, Ph.D., the Company's CEO and CSO, will air on The RedChip Money Report television program. The interview will air Sunday, July 12, at 3 p.m. local time on Bloomberg International, available in 100+ million homes across Europe.

In the exclusive interview, Dr. Shailubhai provides insight into Tiziana's development pipeline and upcoming milestones.

To view the interview segment, please visit: https://youtu.be/ggFJ-XX6C5M

The interview will also air in the US on the Action Channel on Sunday July 12 at 11 a.m. and on My Family TV on Wednesday, July 15 at 6 p.m. and is available via live stream on American Business TV.

"The RedChip Money Report" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.

This will go blue soon.

Just tried to uy. NT. Yet they drop the price to grab sells but turn away buys?

Looks like a buy at close yesterday which drove the price up to 120p?

This has been over 20 mins NT. That's not an orderly market.

Still NT t buy How long can they keep this down?

STill NT to buy.

Agreed Man STEM will be bought long before it gets to market. I would hope 25% is retained by the company and the rest issued to shareholders.

No holdings RNS for several weeks now.

Hey we made it! Something must be brewing here. SHould be fun watching the States this evening.

This is going bonkers.

Can we hit 120p in the next half hour???

Man will you be producing a holdings RNS soon?

Tofay could be a huge jump. Everything is coming together and the market is still behind the curve.

Should be one of those life changing days

See today's BioWorld
Regeneron halts one phase III COVID-19 trial while starting two others
July 6, 2020
By Lee Landenberger
Missing the primary endpoint along with key secondary endpoints in a phase III trial of Kevzara (sarilumab), an interleukin-6 (IL-6) receptor antibody, for treating COVID-19 patients who need mechanical ventilation caused Regeneron Pharmaceuticals Inc. and Sanofi SA to halt the study.

Tarrytown, N.Y.-based Regeneron then followed the closing by initiating two late-stage studies, a phase III and a phase II/III, to evaluate REGN-CoV2, a double antibody ****tail for treating and preventing COVID-19.

The stumble produced a good day for Tiziana Life Sciences plc (NASDAQ:TLSA), whose stock rose 9.6% July 6, closing at $7.19 a share. London-based Tiziana is developing its own anti-IL-6 receptor monoclonal antibody, TZLS-501, to be delivered directly into the lungs of a COVID-19 patient using an inhaler or nebulizer. In April, the company filed a patent application to support the treatment.

Recent valuations before StemPrinter was announced as successful in trials were that TILS was worth about 500p a share. but Tiziana Life Sciences is developing its monoclonal antibody named TZLS-501 for the treatment of COVID-19. TZLS-501 is a human anti-interleukin-6 receptor (IL-6R), which helps in preventing lung damage and elevated levels of IL-6 so the 500p valuation could be meaningless. it could be closer to £10 a share. It all depends on what happens here. Thats the basic share price potential.

The StemPrinter news that it was a 40-50% improvement on the current market leader kind of came out of nowhere. Nobody had really taken much notice of this product before then. STEM though can be valued pretty accurately because 6 months ago Exact Sciences paid £2.8bn for a similar but inferior product. if STEM is 160m shares then each share would be valued at £17.50 maybe more but not really less.
So we can place a current value on TILS of between £20-30 £20 without any COVID19 treatment £30 with.
It might take a year to reach these prices or it might be quicker but one thing is for sure and that is you don't need to look at another share until this happens. It will be the easiest way you ever made money.

Its Friday afternoon and anything can happen. Nice build up of pressure though.

Yes. Its very quiet I expect a drop and a tree shake before too long.